OTTAWA – On Thursday, Senator Jane Cordy and Member of Parliament Dr Kirsty Duncan will testify at the Social Affairs, Science and Technology committee which will begin hearings on Senator Cordy’s Bill S-204, which calls for a national strategy for chronic cerebrospinal venous insufficiency (CCSVI) and multiple sclerosis (MS).
“A national strategy is needed so that MS patients from across Canada can expect the same care and resources no matter where they live in the country” said Senator Cordy. “This is part of the Canada Health Act.”
The bill also calls for clinical trials to put Canada at the forefront of international research in CCSVI as well as proper follow-up care for Canadians living with MS who have had the procedure for CCSVI. Dr. Duncan has sponsored the same bill in the House of Commons.
“While we are encouraged that the government is at last beginning clinical trials for CCSVI, which Liberals asked for in May, 2010, we have concerns that it is not pan-Canadian, and involves only 100 patients,” said Dr. Duncan. “Doctors have been clear that it can take several hundred procedures to be practiced and competent. We are very disappointed that those living with MS are being denied the opportunity to speak at the committee, and we question why known Canadian expert in CCSVI, Dr. Sandy McDonald, is also being prevented from speaking. Why is the government shutting down these important voices?”